Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling-Reference-Cited by-同舟云学术

Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling

Published:2015-12 Issue:7 Volume:163 Page:1716-1729
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

York Autumn G.,Williams Kevin J.,Argus Joseph P.,Zhou Quan D.,Brar Gurpreet,Vergnes Laurent,Gray Elizabeth E.,Zhen Anjie,Wu Nicholas C.,Yamada Douglas H.,Cunningham Cameron R.,Tarling Elizabeth J.,Wilks Moses Q.,Casero David,Gray David H.,Yu Amy K.,Wang Eric S.,Brooks David G.,Sun Ren,Kitchen Scott G.,Wu Ting-Ting,Reue Karen,Stetson Daniel B.,Bensinger Steven J.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference48 articles.

1. Metabolic regulation of mycobacterial growth and antibiotic sensitivity;Baek;PLoS Biol.,2011

2. Sterol uptake in Candida glabrata: rescue of sterol auxotrophic strains;Bard;Diagn. Microbiol. Infect. Dis.,2005

3. Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis;Blanc;PLoS Biol.,2011

4. The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response;Blanc;Immunity,2013

5. Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism;Castrillo;Mol. Cell,2003

Cited by 340 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring common modulations induced by three fish RNA viruses in turbot (Scophthalmus maximus): Cholesterol, vitamin D3 and retinol metabolism as shared targets;Aquaculture;2025-01

2. Metal complex lipid-based nanoparticles deliver metabolism-regulating lomitapide to overcome CTC immune evasion via activating STING pathway;European Journal of Pharmaceutics and Biopharmaceutics;2024-10

3. JAK inhibitor selectivity: new opportunities, better drugs?;Nature Reviews Rheumatology;2024-09-09

4. TGFβ primes alveolar-like macrophages to induce type I IFN following TLR2 activation;2024-09-08

5. Gypenoside L inhibits hepatocellular carcinoma by targeting the SREBP2-HMGCS1 axis and enhancing immune response;Bioorganic Chemistry;2024-09